Total amount raised
$62.9 Millions
Latest funding date
01/01/2023
Location
Paytient has successfully raised funds through multiple rounds, with the latest being a Series B closed on January 10, 2023. The company is backed by 17 investors, including Bertelsmann Investments and Inspired Capital Partners.
Paytient offers a Health Payment Account (HPA) that allows individuals to manage healthcare expenses over time without interest or fees. Keep reading to explore the intricacies of Paytient's fundraising journey and the investors backing this innovative platform.
What Is Paytient?
Paytient, founded in April 2018, is based in Columbia, Missouri. The company operates in the Employee Benefits, FinTech, Health Care, Health Insurance, and Payments industries. It was founded by Brian Whorley and currently employs between 101 and 250 people.
Paytient aims to help individuals make better healthcare decisions by offering payment solutions like the Health Payment Account (HPA) and the Medicare Prescription Payment Plan. These solutions are designed to be bundled or embedded alongside various health plans, empowering users to manage their healthcare expenses more effectively.
How Much Funding Has Paytient Raised?
- Pre-Seed Round
- Amount Raised: $1.3M
- Date: June 2019
- Lead Investors: Cultivation Capital, Lightbank
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To develop the initial product and validate the market need for Health Payment Accounts (HPAs).
- Seed Round
- Amount Raised: $3.9M
- Date: October 2020
- Lead Investors: Inspired Capital Partners
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To expand the team and enhance the platform's capabilities.
- Series A
- Amount Raised: $17.2M
- Date: July 2021
- Lead Investors: Inspired Capital Partners
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To scale operations and increase market penetration.
- Series B
- Amount Raised: $33M
- Date: January 2023
- Lead Investors: Mercato Partners
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To scale growth and product development.
- Debt Financing
- Amount Raised: $7.5M
- Date: January 2023
- Lead Investors: Silicon Valley Bank
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To support operational expenses and further product development.
Total Amount Raised: $62.9M. Current Valuation: Not publicly disclosed.
Key Investors
- Mercato Partners Traverse Fund
- Details: Mercato Partners Traverse Fund is a growth-stage investment firm. Joe Kaiser, a managing director at Mercato Partners, has joined Paytient’s board of directors.
- Investment Focus Areas: Healthcare, financial solutions, high-growth companies.
- Notable Investments: Not publicly disclosed.
- Inspired Capital Partners
- Details: Inspired Capital Partners is an early-stage venture capital firm. They led Paytient’s Seed and Series A rounds.
- Investment Focus Areas: Early-stage companies, innovative solutions, technology.
- Notable Investments: Not publicly disclosed.
- Bertelsmann Investments
- Details: Bertelsmann Investments is the venture capital arm of Bertelsmann, a global media, services, and education company. Thorsten Wirkes from Bertelsmann Investments has joined Paytient’s board as an observer.
- Investment Focus Areas: Innovative companies, various sectors including healthcare.
- Notable Investments: Not publicly disclosed.
- Lightbank
- Details: Lightbank is a venture capital firm that invests in early-stage technology companies. They are an existing investor in Paytient.
- Investment Focus Areas: Early-stage technology, disruptive technology companies.
- Notable Investments: Not publicly disclosed.
- Silicon Valley Bank
- Details: Silicon Valley Bank provides financial services and debt financing to technology and life sciences companies. They provided $7.5 million in debt financing to Paytient.
- Investment Focus Areas: Technology, life sciences, financial services.
- Notable Investments: Not publicly disclosed.
What's Next for Paytient?
Paytient stands at the cusp of significant growth opportunities. With nearly 700 enterprise partners and serving 700,000 lives, the company is poised to expand its Health Payment Accounts (HPAs) offering. The rising financial strain from unexpected healthcare costs presents a substantial market for Paytient's interest-free credit solutions.
Future fundraising appears promising, with the successful Series B round indicating potential for additional funding. As the company scales, strategic investments from healthcare providers or insurers could further bolster its growth. However, challenges such as competition from other fintech solutions and navigating regulatory landscapes remain. Ensuring widespread adoption and managing financial risks will be crucial as Paytient continues to innovate in the healthcare payment space.
Use Clay to Get Funding Data
Sales professionals, leverage Clay’s platform to access comprehensive fundraising data on companies like Paytient and gather other critical business insights. Sign up for free to start making informed decisions today.
